In short: Not owned; down on margins & order growth. Dominant device franchise but slowing growth → de-rating risk; "too hard" bucket alongside the medtech peers.
31:01reasons. Boston Scientific had some issues with their Watchman product and GE Healthcare because of their margins
31:09and order growth. Are these stock specific selloffs or is it a broader warning for medtech? So I think medtech
Nothing matches this filter.
Verbatim excerpts from the public transcripts (auto-pulled at each mention's timestamp, lightly cleaned). Timestamps link into the video; "source page" opens that commentator's full analysis at this row. Click a mention's header line to expand it (one open at a time). For personal study — not investment advice.